Cumberland Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
|
|||||
2022
Q3 | $13.5M | Sell |
|
|||||
2022
Q2 | $13.2M | Sell |
|
|||||
2022
Q1 | $28.4M | Buy |
|
|||||
2021
Q4 | $28.4M | Sell |
|
|||||
2021
Q3 | $32.3M | Buy |
|
|||||
2021
Q2 | $32.1M | Buy |
|
|||||
2021
Q1 | $23.2M | Buy |
|
|||||
2020
Q4 | $23.7M | Buy |
|
|||||
2020
Q2 | $13.5M | Sell |
|
|||||
2020
Q1 | $16.1M | Sell |
|
|||||
2019
Q4 | $19.8M | Sell |
|
|||||
2019
Q3 | $16.1M | Buy |
|
|||||
2019
Q2 | $18.1M | Sell |
|
|||||
2019
Q1 | $18.9M | Buy |
|
|||||
2018
Q4 | $13.3M | Buy |
|
|||||
2018
Q3 | $5.43M | Buy |
|
|||||
2018
Q2 | $4.11M | Buy |
|
|||||
2018
Q1 | $3.68M | Buy |
|
|||||
2017
Q4 | $3.54M | Buy |
|
|||||
2017
Q3 | $355K | Sell |
|
|||||
2017
Q2 | $321K | Hold |
|
|||||
2017
Q1 | $288K | Sell |
|
|||||
2016
Q4 | $323K | Buy |
|
|||||
2016
Q2 | – | Sell |
|
|||||
2016
Q1 | $1.97M | Buy |
|
|||||
2013
Q4 | – | Sell |
|
|||||
2013
Q3 | $3.36M | Buy |
|
|||||
2013
Q2 | $2.08M | Buy |
|